Trials / Conditions / Signet Ring Adenocarcinoma of the Rectum

Signet Ring Adenocarcinoma of the Rectum

20 registered clinical trials studyying Signet Ring Adenocarcinoma of the Rectum.

Status	Trial	Sponsor	Phase
Terminated	Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Sprea NCT02110953	Fox Chase Cancer Center	Phase 1
Withdrawn	Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With St NCT02235324	University of Southern California	Phase 2
Completed	CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surg NCT02232152	Wake Forest University Health Sciences	Phase 1
Completed	Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal Cancer NCT02270606	Virginia Commonwealth University	Phase 1
Completed	Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Adv NCT02132858	Fox Chase Cancer Center	—
Terminated	Telomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing Chemot NCT01934179	Fox Chase Cancer Center	—
Unknown	Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage NCT01871571	University of Southern California	Phase 2
Completed	Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer NCT01923337	University of California, Davis	Phase 1
Completed	Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab NCT01814501	John Hays	Phase 2
Completed	Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorect NCT01726296	Fox Chase Cancer Center	N/A
Completed	Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer NCT01652196	John Hays	Phase 2
Withdrawn	Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer NCT01403103	Case Comprehensive Cancer Center	EARLY_Phase 1
Completed	Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointest NCT01643499	University of Chicago	Phase 1
Terminated	Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal NCT01285102	Fox Chase Cancer Center	Phase 1
Terminated	Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surg NCT00835679	National Cancer Institute (NCI)	EARLY_Phase 1
Completed	A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, an NCT00060411	National Cancer Institute (NCI)	Phase 1
Terminated	Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer NCT00052585	National Cancer Institute (NCI)	Phase 2
Completed	Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer NCT00005036	National Cancer Institute (NCI)	Phase 3
Completed	Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer NCT00003799	National Cancer Institute (NCI)	Phase 1
Terminated	Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer NCT00002796	National Cancer Institute (NCI)	Phase 1 / Phase 2